The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression
Vincent Van den Eynde, Wegdan R. Abdelmoemin, Magid M. Abraham, Jay D. Amsterdam, Ian Anderson, Chittaranjan Andrade, Glen B. Baker, Aartjan T.F. Beekman, Michael Berk, Tom K. Birkenhäger, Barry Blackwell, Pierre Blier, Marc B.J. Blom, Alexander J. Bodkin, C Cattaneo, Bezalel Dantz, Jonathan Davidson, Boadie W. Dunlop, Ryan F. Estévez, Shalom S. Feinberg, J. P. M. Finberg, Laura J. Fochtmann, David Gotlib, Andrew Holt, Thomas R. Insel, Jens Larsen, Rohit Mago, David B Menkes, Jonathan M. Meyer, David Nutt, Gordon Parker, Mark D. Rego, Elliott Richelson, Henricus G. Ruhé, Jerónimo Sáiz-Ruiz, Stephen M. Stahl, Thomas G. Steele, Michael E. Thase, S. Ulrich, Anton J.L.M. van Balkom, Eduard Vieta, Ian M. Whyte, Allan H. Young, Peter Kenneth Gillman (2022). The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. , 28(4), DOI: https://doi.org/10.1017/s1092852922000906.
